Clinical Study
Platelet Counts and Platelet Activation Markers in Obese Subjects
Table 1
Clinical characteristics of subjects for platelet count analysis stratified by BMI.
| | BMI | <25 | 25–29.9 | 30–39.9 | >40 | P-value |
| | n | 2460 | 2749 | 1057 | 49 | — | | Age (mean ± SD) | yrs | yrs | yrs | yrs | <.0001 | | Hypertension | 246 (10.0%) | 596 (21.7%) | 370 (35%) | 22 (44.9%) | <.0001 | | Diabetes mellitus | 38 (1.5%) | 91 (3.3%) | 106 (10.0%) | 11 (22.4%) | <.0001 | | Dyslipidemia | 451 (18.3%) | 911 (33.1%) | 451 (51.1%) | 20 (40.8%) | <.0001 | | Ischemic heart disease | 30 (1.2%) | 35 (1.3%) | 19 (1.8%) | 1 (2.0%) | .53 | | Past CVA | 4 (0.2%) | 1 (0.0%) | 3 (0.3%) | 1 (0.02%) | .001 |
|
|
BMI = body mass index; MI =
myocardial infarction; CVA = cerebrovascular accident.
|
